Choice of replacement therapy for hemophilia.
Aledort
L M
LM
D016913:Blood Component Transfusion / Q000009:adverse effects; D003657:Decision Making; D005169:Factor VIII / Q000008:administration & dosage / Q000627:therapeutic use; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D005169:Factor VIII